Dustin G. Mark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dustin G. Mark has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- David Russell Vinson
Kaiser Permanente CREST Network, Pleasanton, California, USA
22 shared publications Jie Huang
19 shared publicationsMary E. Reed
Division of Research, Kaiser Permanente Northern California, Pleasanton, USA
17 shared publications- Dustin W. Ballard
Kaiser Permanente Division of Research, Pleasanton, CA; Kaiser Permanente Medical Center, San Rafael, CA
11 shared publications Dana R. Sax
10 shared publications- Mary E. Reed
Kaiser Permanente Division of Research , Pleasanton, California
10 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Springer Nature in Research Square
Osmotic demyelination syndrome in severe hyponatremia: independent association with sodium correction rates when accounting for established risk factors.
Introduction: Clinical guidelines emphasize slow correction of severe hyponatremia to prevent osmotic demyelination syndrome (ODS), but there is sparse data on relative impact of ODS risk factors. Methods Retrospective cohort study of adults with an initial serum sodium concentration ≤ 120 meq/L admitted to a 21-hospital integrated healthcare system between January 1, 2008 to December 31, 2023. Maximum 24-hour sodium correction was defined as slow (< 6 meq/L), moderate (8–12 meq/L) or fast (> 12 meq/L). Adjusted odds ratios (aOR) were determined using Firth’s penalized logistic regression. Results Of 16,021 patients, 23 (0.14%) cases of ODS were identified. Compared to ODS cases had lower initial serum sodium (112 vs 117 meq/L) and were more likely to have a major ODS risk factor (70% vs 23%) and undergo fast sodium correction (43% vs 24%). Initial serum sodium ≤ 105 meq/L (aOR 10.3, 95% CI 3.3 to 32.3), initial serum potassium < 3.0 meq/L (aOR 3.4, 95% CI 1.2 to 9.3), and history of alcohol abuse (aOR 3.9, 95% CI 1.7 to 8.8) were independently associated with ODS; the maximum rate of sodium correction was not. Conclusion Baseline risk factors are far more deterministic of ODS than marginal differences in sodium correction rates.
- 24 June 2026
- Published by Springer Nature in Research Square
Open AccessOsmotic demyelination syndrome in severe hyponatremia: independent association with sodium correction rates when accounting for established risk factors.
Introduction: Clinical guidelines emphasize slow correction of severe hyponatremia to prevent osmotic demyelination syndrome (ODS), but there is sparse data on relative impact of ODS risk factors. Methods Retrospective cohort study of adults with an initial serum sodium concentration ≤ 120 meq/L admitted to a 21-hospital integrated healthcare system between January 1, 2008 to December 31, 2023. Maximum 24-hour sodium correction was defined as slow (< 6 meq/L), moderate (8–12 meq/L) or fast (> 12 meq/L). Adjusted odds ratios (aOR) were determined using Firth’s penalized logistic regression. Results Of 16,021 patients, 23 (0.14%) cases of ODS were identified. Compared to ODS cases had lower initial serum sodium (112 vs 117 meq/L) and were more likely to have a major ODS risk factor (70% vs 23%) and undergo fast sodium correction (43% vs 24%). Initial serum sodium ≤ 105 meq/L (aOR 10.3, 95% CI 3.3 to 32.3), initial serum potassium < 3.0 meq/L (aOR 3.4, 95% CI 1.2 to 9.3), and history of alcohol abuse (aOR 3.9, 95% CI 1.7 to 8.8) were independently associated with ODS; the maximum rate of sodium correction was not. Conclusion Baseline risk factors are far more deterministic of ODS than marginal differences in sodium correction rates.
- Top Cited Papers
- 1 March 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (3) , 330-339
Sodium Correction Rates and Associated Outcomes Among Patients With Severe Hyponatremia
Slow correction of severe hyponatremia is recommended to prevent osmotic demyelination syndrome but is associated with higher mortality. To examine the association between sodium correction rates and death or delayed neurologic events. Retrospective cohort study. Twenty-one community hospitals of an integrated health system in northern California. Adults hospitalized with a serum sodium level of 120 mEq/L or lower between 2008 and 2023. Maximum 24-hour rate of serum sodium correction (slow [12 mEq/L; reference]). The primary outcome was a composite of 90-day death or delayed neurologic events (new demyelination, paralysis, epilepsy, or altered consciousness between 3 and 90 days from admission). Standardized risk differences (RDs) were generated using targeted maximum likelihood estimation. Heterogeneity of effect was assessed across grades of predicted risk. 13 988 patients were hospitalized with severe hyponatremia during the study period (median age, 74 years; 63% female). Comorbidities included congestive heart failure (24%), liver disease (18%), alcohol dependence (14%), and metastatic cancer (10%). The primary outcome occurred in 3000 patients (21%); 90-day death occurred in 2554 (18%), and 90-day delayed neurologic events occurred in 587 (4%). Compared with slow 24-hour sodium correction, both medium (RD, -5.6 percentage points [95% CI, -7.1 to -4.0 percentage points]) and fast (RD, -9.0 percentage points [CI, -11.1 to -6.9 percentage points]) correction rates were associated with lower adjusted risk for the primary outcome. Risk differences increased with higher predicted risk, whereas risk ratios remained similar. Residual confounding; outcome ascertainment using diagnostic codes. Faster sodium correction is associated with lower risk for 90-day death or delayed neurologic events. Treatment guidelines should be reexamined. The Permanente Medical Group Rapid Analytics Unit Program.
- 1 March 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (3) , 330-339
Top Cited PapersSodium Correction Rates and Associated Outcomes Among Patients With Severe Hyponatremia
Slow correction of severe hyponatremia is recommended to prevent osmotic demyelination syndrome but is associated with higher mortality. To examine the association between sodium correction rates and death or delayed neurologic events. Retrospective cohort study. Twenty-one community hospitals of an integrated health system in northern California. Adults hospitalized with a serum sodium level of 120 mEq/L or lower between 2008 and 2023. Maximum 24-hour rate of serum sodium correction (slow [12 mEq/L; reference]). The primary outcome was a composite of 90-day death or delayed neurologic events (new demyelination, paralysis, epilepsy, or altered consciousness between 3 and 90 days from admission). Standardized risk differences (RDs) were generated using targeted maximum likelihood estimation. Heterogeneity of effect was assessed across grades of predicted risk. 13 988 patients were hospitalized with severe hyponatremia during the study period (median age, 74 years; 63% female). Comorbidities included congestive heart failure (24%), liver disease (18%), alcohol dependence (14%), and metastatic cancer (10%). The primary outcome occurred in 3000 patients (21%); 90-day death occurred in 2554 (18%), and 90-day delayed neurologic events occurred in 587 (4%). Compared with slow 24-hour sodium correction, both medium (RD, -5.6 percentage points [95% CI, -7.1 to -4.0 percentage points]) and fast (RD, -9.0 percentage points [CI, -11.1 to -6.9 percentage points]) correction rates were associated with lower adjusted risk for the primary outcome. Risk differences increased with higher predicted risk, whereas risk ratios remained similar. Residual confounding; outcome ascertainment using diagnostic codes. Faster sodium correction is associated with lower risk for 90-day death or delayed neurologic events. Treatment guidelines should be reexamined. The Permanente Medical Group Rapid Analytics Unit Program.
- 1 February 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (2) , e2600503OC
Annals On Call - Hyponatremia Correction: How Fast Is Too Fast?
- 1 February 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (2) , e2600503OC
Annals On Call - Hyponatremia Correction: How Fast Is Too Fast?
- Open Access
- 7 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (19) , e043756
Validation of a 0‐/2‐Hour High‐Sensitivity Cardiac Troponin Algorithm for Suspected Acute Coronary Syndrome in the Emergency Department
Background: We implemented a hs‐cTnI (high‐sensitivity cardiac troponin I)‐based algorithm for emergency department (ED) evaluation of possible non‐ST–segment‐elevation acute coronary syndrome within an integrated health system (Kaiser Permanente Northern California). Methods: Retrospective study of adult (18+ years) ED encounters for chest pain/discomfort with hs‐cTnI testing (Access hsTnI, Beckman) at 21 medical centers between January 1, 2023 and June 30, 2024, excluding ST–segment‐elevation myocardial infarction. The primary outcome was 30‐day myocardial infarction or death. Sensitivity, specificity, negative predictive value, positive predictive value, and likelihood ratios were reported, with subgroup analyses by age, sex, coronary artery disease, chronic kidney disease, and ED disposition. Results: There were 104 025 encounters in the final cohort (median age 59 years, 45% male, 18% coronary artery disease, and 13% chronic kidney disease). The primary outcome occurred in 5.5% encounters. Rule‐out criteria were present in 70% of encounters (sensitivity, 95.4% [95% CI, 94.8%–96.0%]; negative predictive value, 99.7% [95% CI, 99.6%–99.7%]; likelihood ratio, −0.05) and 7% of encounters met rule‐in criteria (specificity, 96.7% [95% CI, 96.6–96.8%]; positive predictive value, 60.2% [95% CI, 59.3%–61.1%]; likelihood ratio, +24.4). In subgroup analyses, rule‐out criteria negative predictive value was below 99% in stage 4+ chronic kidney disease (96.1% [95% CI, 94.6%–97.6%]) and ischemic coronary artery disease (98.6% [95% CI 98.3–98.9%]), though not among those selected for ED discharge (98.4% [95% CI, 96.7%–99.2%] and 99.1% [95% CI, 98.8%–99.4%], respectively). Conclusions: The Kaiser Permanente Northern California non‐ST–elevation acute coronary syndrome evaluation algorithm demonstrated excellent overall performance. Negative predictive value was modestly diminished in ischemic coronary artery disease or advanced chronic kidney disease, but risk was largely mitigated by ED discharge disposition decisions.
- 7 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (19) , e043756
Open AccessValidation of a 0‐/2‐Hour High‐Sensitivity Cardiac Troponin Algorithm for Suspected Acute Coronary Syndrome in the Emergency Department
Background: We implemented a hs‐cTnI (high‐sensitivity cardiac troponin I)‐based algorithm for emergency department (ED) evaluation of possible non‐ST–segment‐elevation acute coronary syndrome within an integrated health system (Kaiser Permanente Northern California). Methods: Retrospective study of adult (18+ years) ED encounters for chest pain/discomfort with hs‐cTnI testing (Access hsTnI, Beckman) at 21 medical centers between January 1, 2023 and June 30, 2024, excluding ST–segment‐elevation myocardial infarction. The primary outcome was 30‐day myocardial infarction or death. Sensitivity, specificity, negative predictive value, positive predictive value, and likelihood ratios were reported, with subgroup analyses by age, sex, coronary artery disease, chronic kidney disease, and ED disposition. Results: There were 104 025 encounters in the final cohort (median age 59 years, 45% male, 18% coronary artery disease, and 13% chronic kidney disease). The primary outcome occurred in 5.5% encounters. Rule‐out criteria were present in 70% of encounters (sensitivity, 95.4% [95% CI, 94.8%–96.0%]; negative predictive value, 99.7% [95% CI, 99.6%–99.7%]; likelihood ratio, −0.05) and 7% of encounters met rule‐in criteria (specificity, 96.7% [95% CI, 96.6–96.8%]; positive predictive value, 60.2% [95% CI, 59.3%–61.1%]; likelihood ratio, +24.4). In subgroup analyses, rule‐out criteria negative predictive value was below 99% in stage 4+ chronic kidney disease (96.1% [95% CI, 94.6%–97.6%]) and ischemic coronary artery disease (98.6% [95% CI 98.3–98.9%]), though not among those selected for ED discharge (98.4% [95% CI, 96.7%–99.2%] and 99.1% [95% CI, 98.8%–99.4%], respectively). Conclusions: The Kaiser Permanente Northern California non‐ST–elevation acute coronary syndrome evaluation algorithm demonstrated excellent overall performance. Negative predictive value was modestly diminished in ischemic coronary artery disease or advanced chronic kidney disease, but risk was largely mitigated by ED discharge disposition decisions.
- 8 August 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 440, 133730
Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation
- 8 August 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 440, 133730
Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation
- Open Access
Validation of a 0/2-hour high sensitivity cardiac troponin algorithm for suspected acute coronary syndrome in the emergency department
Background: We implemented a high-sensitivity cardiac troponin I (hs-cTnI)-based algorithm for emergency department (ED) evaluation of possible non-ST elevation acute coronary syndromes (NSTE-ACS) within an integrated health system (The Kaiser Permanente Northern California [KPNC] NSTE-ACS algorithm). Methods: Retrospective study of adult (18+ years) ED encounters for chest pain/discomfort with hs-cTnI testing (Access hsTnI, Beckman) at 21 KPNC medical centers between January 1, 2023 and June 30, 2024. Exclusion criteria were ST-elevation myocardial infarction (MI), leaving the ED against medical advice, lack of active KP health plan coverage, or an included encounter within 30 days prior. The primary outcome was 30-day MI or death. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and likelihood ratios (LR) were reported, with subgroup analyses by age, sex, coronary artery disease (CAD), chronic kidney disease (CKD), and ED disposition. Results: There were 104,025 encounters in the final study cohort. Median age was 59 years, 45% were male, 18% had CAD, and 13% had CKD. The primary outcome occurred in 5.5% of encounters. Rule-out criteria were present in 70% of encounters with a sensitivity of 95.4% (95% CI: 94.8-96.0%), a NPV of 99.7% (95% CI: 99.6-99.7%) and an LR-of 0.05, while 7% of encounters met rule-in criteria with a specificity of 96.7% (95% CI: 96.6-96.8%), a PPV of 60.2% (95% CI: 59.3-61.1%) and an LR+ of 24.4. In subgroup analyses, rule-out criteria NPV was statistically below 99% in stage 4+ CKD (96.1%; 95% CI: 94.6-97.6%) and ischemic CAD (98.6%; 95% CI: 98.3-98.9%), though not among those selected for ED discharge (98.4%; 95% CI: 96.7-99.2% and 99.1%; 95% CI: 98.8-99.4%, respectively). Conclusions: The KPNC NSTE-ACS evaluation algorithm demonstrated excellent overall performance. NPV was modestly diminished in ischemic CAD or advanced CKD, but this excess risk was largely mitigated by ED discharge disposition decisions.
Open AccessValidation of a 0/2-hour high sensitivity cardiac troponin algorithm for suspected acute coronary syndrome in the emergency department
Background: We implemented a high-sensitivity cardiac troponin I (hs-cTnI)-based algorithm for emergency department (ED) evaluation of possible non-ST elevation acute coronary syndromes (NSTE-ACS) within an integrated health system (The Kaiser Permanente Northern California [KPNC] NSTE-ACS algorithm). Methods: Retrospective study of adult (18+ years) ED encounters for chest pain/discomfort with hs-cTnI testing (Access hsTnI, Beckman) at 21 KPNC medical centers between January 1, 2023 and June 30, 2024. Exclusion criteria were ST-elevation myocardial infarction (MI), leaving the ED against medical advice, lack of active KP health plan coverage, or an included encounter within 30 days prior. The primary outcome was 30-day MI or death. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and likelihood ratios (LR) were reported, with subgroup analyses by age, sex, coronary artery disease (CAD), chronic kidney disease (CKD), and ED disposition. Results: There were 104,025 encounters in the final study cohort. Median age was 59 years, 45% were male, 18% had CAD, and 13% had CKD. The primary outcome occurred in 5.5% of encounters. Rule-out criteria were present in 70% of encounters with a sensitivity of 95.4% (95% CI: 94.8-96.0%), a NPV of 99.7% (95% CI: 99.6-99.7%) and an LR-of 0.05, while 7% of encounters met rule-in criteria with a specificity of 96.7% (95% CI: 96.6-96.8%), a PPV of 60.2% (95% CI: 59.3-61.1%) and an LR+ of 24.4. In subgroup analyses, rule-out criteria NPV was statistically below 99% in stage 4+ CKD (96.1%; 95% CI: 94.6-97.6%) and ischemic CAD (98.6%; 95% CI: 98.3-98.9%), though not among those selected for ED discharge (98.4%; 95% CI: 96.7-99.2% and 99.1%; 95% CI: 98.8-99.4%, respectively). Conclusions: The KPNC NSTE-ACS evaluation algorithm demonstrated excellent overall performance. NPV was modestly diminished in ischemic CAD or advanced CKD, but this excess risk was largely mitigated by ED discharge disposition decisions.
- 8 May 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 251, 25-33
Implementation of a High-Sensitivity Cardiac Troponin Assay and Diagnostic Protocol for Suspected Acute Coronary Syndrome
- 8 May 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 251, 25-33
Implementation of a High-Sensitivity Cardiac Troponin Assay and Diagnostic Protocol for Suspected Acute Coronary Syndrome
- 9 April 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (6) , 958-969
Prospective Validation and Implementation Pilot Study of an Emergency Department Heart Failure Risk Stratification Tool
- 9 April 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (6) , 958-969
Prospective Validation and Implementation Pilot Study of an Emergency Department Heart Failure Risk Stratification Tool